Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-915-2013

Drug recall · August 28, 2013

IRINOTECAN HYDROCHLORIDE INJECTION recall

Why: Crystallization: Active pharmaceutical ingredient is precipitating in product solution.

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

IRINOTECAN HYDROCHLORIDE INJECTION, 40 mg/2 mL (20 mg/mL), 2 mL Single Dose Vial, Rx only, Manufactured for: APP Pharmaceuticals, LLC, Schaumburg, IL 60173, NDC 63323-193-02, UPC 3 63323 19302 7.

Lots / codes

Lot #: 872CZ00101, Exp 12/13

Quantity
23,672 vials
Company
Fresenius Kabi USA LLC (FK USA), Schaumburg, IL
Distribution
Nationwide
Initiated
January 22, 2013 · Voluntary: Firm initiated
Classified
August 21, 2013
Reported
August 28, 2013
Ended
May 12, 2015
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Irinotecan

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.